Advertisements

Amlibon B Sandoz

Quick links to important sections

Amlibon B Sandoz

Advertisements
Advertisements

Method of action: Antihypertensive

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amlibon B Sandoz

What is Amlibon B Sandoz?

Amlibon B Sandoz is a combination pharmaceutical product containing two active medicinal substances: amlodipine and bisoprolol. Each of these components belongs to a different class of medications, and they work through different mechanisms to manage cardiovascular conditions.

Component Overview

  • Amlodipine: This substance belongs to a group of medicines known as calcium channel blockers. It acts primarily on the blood vessels, causing the smooth muscle walls of the arteries to relax. This action helps to widen the blood vessels, making it easier for blood to flow through them.
  • Bisoprolol: This substance belongs to a group of medicines called beta-blockers. It acts by affecting the heart's response to certain nerve impulses. Its primary function is to slow down the heart rate and improve the heart's efficiency in pumping blood throughout the body.

Therapeutic Purpose

Amlibon B Sandoz is utilized for the treatment of high blood pressure (hypertension). It is typically prescribed for patients whose blood pressure is already adequately controlled by taking amlodipine and bisoprolol as separate tablets at the same dose levels found in the combination product.

By combining these two agents into a single capsule, the medication addresses blood pressure management from two angles: reducing the resistance in the peripheral blood vessels and regulating the workload of the heart. This integrated approach helps in maintaining stable blood pressure levels in patients for whom this specific combination of active ingredients has been deemed appropriate.

Advertisements

What side effects are possible with Amlibon B Sandoz?

Possible side effects and safety information

The official safety profile for Amlodipine/Benazepril is structured around known adverse reactions and specific regulatory constraints, as documented by government health authorities. Reactions are generally classified by frequency and the body system affected.

Frequency-Classified Adverse Reactions

Side effects that are officially classified as common include edema (swelling, particularly of the extremities), a persistent cough, headache, and dizziness. Regulatory documents note that edema and cough are the most frequent reasons for discontinuing the medicine. Less common effects may involve palpitations, nervousness, and rash.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions, though rare, are officially documented. The most notable is Angioedema, which involves severe swelling of the face, tongue, and throat, and is considered potentially fatal. Other serious documented reactions include Hepatic Failure (severe liver damage) and Acute Renal Failure. The medicine is strictly contraindicated in patients with a history of Angioedema, known hypersensitivity, or when used concurrently with certain other medications such as Sacubitril-containing products.

Population and Time-Related Safety

Specific safety considerations exist for certain populations. The medicine is formally contraindicated during pregnancy due to a high risk of fetal harm and mortality. The official label also notes that Black patients may have a higher incidence of Angioedema. Regarding timing, regulatory data indicates that dizziness and headache may be more likely at the beginning of treatment, while Angioedema can occur after initial doses or following months of therapy.

Advertisements

Overdose and Emergency Response

Overdose with Amlibon B Sandoz (Amlodipine/Benazepril) primarily presents through the physiological effects of profound vasodilation, which results in severe and prolonged hypotension (low blood pressure). Officially documented manifestations may include dizziness, syncope (fainting), and disturbances in heart rate, such as reflex tachycardia or marked bradycardia. Overdose of this fixed-dose combination carries the risk of progression to severe, life-threatening outcomes, including circulatory shock and acute renal failure.

Immediate regulatory guidance mandates that anyone suspecting an overdose must seek immediate medical attention. According to official statements, emergency services must be called immediately if the person exhibits severe symptoms such as collapse, a seizure, trouble breathing, or if they can’t be awakened. A certified Regional Poison Control Center is also an officially advised resource for information regarding treatment.

Management, as documented in regulatory information, consists of symptomatic and supportive treatment. While no specific antidote is known for the combination, treatment may involve intravenous fluid repletion and the use of pressor agents to counteract severe hypotension. Intensive cardiac and renal monitoring is required, as the components' high protein binding and limited dialyzability make hemodialysis an unlikely method for drug removal.

Advertisements

Therapeutic Uses of Amlibon B Sandoz

What Amlibon B Sandoz Treats: Main Uses and Benefits

The primary therapeutic benefit of this fixed-dose combination generally involves the intensified and sustained management of chronic high blood pressure. It is typically applied in adult patients when blood pressure requires additional management beyond a single medication.

Intensified Blood Pressure Control

This combination is commonly used in conditions characterized by periods of heightened physiological stress where blood pressure management requires comprehensive support. It helps support functional stability by addressing systemic vascular stress associated with essential hypertension. The medication is relevant for managing symptoms that create noticeable physiological strain, assisting with a more consistent control of blood pressure throughout the 24-hour cycle. Indications include essential hypertension and conditions where blood pressure is not adequately controlled on monotherapy.

“This fixed-dose strategy assists with maintaining functional stability by supporting sustained control of systemic pressure.”

Long-Term Cardiovascular and Organ Protection

This therapeutic domain is relevant when supportive symptom management is appropriate to help ease symptoms linked to organ-specific functional stress caused by prolonged, elevated blood pressure. The key patient benefit assists with reducing the probability of future symptoms that interfere with daily functioning, such as those linked to heightened cardiovascular risk. This use is common in patients with multiple cardiovascular risk factors.


Quick Fact: Relief for Uncontrolled Pressure
Main Therapeutic Aim Achieving sustained and comprehensive control of blood pressure when monotherapy is insufficient.
Benefit Focus Easing the impact of symptoms linked to organ-specific functional stress on the heart and kidneys.
Common Scenario Long-term management for adults whose condition is marked by increased physiological stress and requires intensified support.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility and Contraindications

Amlibon B Sandoz is a prescription medicine containing amlodipine, and its use is strictly governed by documented regulatory standards regarding patient eligibility.

Population Status Eligibility Rule (Official Classification)
Populations Contraindicated Must NOT use. Individuals with a known hypersensitivity or allergy to amlodipine or any other dihydropyridine derivatives (e.g., nifedipine, felodipine). Also excluded are patients experiencing severe hypotension, shock (including cardiogenic shock), unstable heart failure after an acute myocardial infarction, or obstruction of the left ventricular outflow tract (such as high-grade aortic stenosis).
Lactation Contraindicated. Use is prohibited during breast-feeding, as the medicine is present in breast milk.
Pediatric Eligibility Recommended for use in children aged 6 to 17 years for the treatment of hypertension. Use in children younger than 6 years is not recommended due to a lack of established safety and efficacy data.
Special Caution Required Patients with hepatic impairment (liver problems) should use the medicine with caution, as clearance of the drug may be reduced. Use in the elderly also requires care due to the greater likelihood of decreased organ function.

All decisions regarding the use of this medication must be made by a healthcare professional, considering the patient’s complete medical status against these documented regulatory criteria.

Advertisements

What should I know about interactions with other medicines?

Amlibon B Sandoz contains amlodipine, a calcium channel blocker, and B vitamins. While B vitamins generally have few significant drug interactions, the amlodipine component can interact with several medications, potentially altering the drug's effectiveness or increasing the risk of side effects.

It is essential to inform your doctor or pharmacist about all prescription, over-the-counter medicines, and herbal supplements you are taking.

Medications that Increase Amlodipine Effect

Some medicines can increase the concentration of amlodipine in the blood, raising the risk of side effects such as very low blood pressure (hypotension) and swelling (edema). Close monitoring is required if Amlibon B Sandoz is taken with:

  • Certain antifungals: Such as ketoconazole and itraconazole.
  • Certain antibiotics: Such as clarithromycin and erythromycin.
  • HIV/HCV treatments: Including ritonavir-containing regimens.
  • Other blood pressure medicines: The combined effect may lower blood pressure excessively.

Medications that Decrease Amlodipine Effect

Certain medicines can reduce the amount of amlodipine in the blood, making Amlibon B Sandoz less effective. Examples include:

  • Rifampicin (an antibiotic).
  • Certain anti-epileptic drugs: Such as carbamazepine, phenytoin, and phenobarbital.
  • St. John's wort (a herbal product).

Other Important Interactions

  • Simvastatin (for high cholesterol): Amlodipine can increase simvastatin levels. Dosing should be limited to avoid muscle-related side effects.
  • Grapefruit or grapefruit juice can significantly increase amlodipine levels and should be avoided.
  • Sildenafil and similar erectile dysfunction medications may lead to excessive drops in blood pressure when combined with amlodipine.
Advertisements

Mechanism of Action

Amlibon B Sandoz contains a dihydropyridine compound that functions as a calcium channel blocker. Its mechanism of action begins with a highly selective interaction at the L-type voltage-gated calcium channels (VGCCs) located on the membranes of vascular smooth muscle cells.

Binding to these channels inhibits the transmembrane influx of extracellular calcium ions into the cells. This molecular event directly interferes with the signaling cascade required for muscle contraction. The resulting decrease in intracellular calcium concentration diminishes the contractile tone, inducing vasodilation (relaxation and widening of the systemic arteries).

This mechanistic effect reduces the overall peripheral vascular resistance and the mechanical load against which the heart pumps (afterload). Furthermore, the same mechanism is applied to the coronary arteries, influencing their tone and diameter. This modulation of vascular pathways is associated with an increase in blood flow and oxygen supply capacity to the myocardial tissue.

Advertisements

Dosage and Administration Information

Amlibon B Sandoz is administered orally as a fixed-dose capsule on a once-daily schedule. The medication must be taken at the same time each day to maintain consistent blood concentrations of both active components, an instruction that applies regardless of meal timing—the capsule may be consumed with or without food.

This combination is not intended for the initiation of hypertension therapy; instead, it is applied when a patient's blood pressure is not adequately managed by monotherapy with either a calcium channel blocker or an ACE inhibitor alone. The standard initial strength is a capsule containing amlodipine 2.5 mg and benazepril 10 mg. Dosage may be increased incrementally up to a maximum of amlodipine 10 mg and benazepril 40 mg once daily, provided a minimum period of approximately two weeks has elapsed between adjustments to accurately assess the full therapeutic response.

Official recommendations define specific constraints for certain patient populations. Individuals who are older or who have hepatic impairment should begin on the lowest available combination strength. Furthermore, the use of this product is generally not recommended for individuals with severe renal impairment, defined by a creatinine clearance of CrCl ≤ 30 mL/min. If a dose is missed by more than twelve hours, official instructions advise skipping the missed dose entirely and resuming the regular daily schedule.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amlibon B Sandoz

Evidence for use in Intensified Blood Pressure Control

The combination of Amlodipine and Benazepril was studied for use in adults with high blood pressure, particularly in conditions where symptoms may vary in intensity or when systolic hypertension is present. Researchers conducted randomized controlled trials (RCTs) primarily including patients whose blood pressure had not been adequately controlled while they were receiving single-agent therapy.

The main outcomes related to systemic or functional imbalance that research examined included the change in blood pressure measured in a clinic setting, as well as the patterns measured over 24 hours. Trials examined the measured differences in blood pressure metrics when the two agents were combined versus when the single agents were used. Furthermore, data show patterns related to a higher proportion of patients reaching predefined pressure goals when the combination was utilized.


Long-Term Cardiovascular Protection and Follow-up

Major, long-term clinical research that included patients with hypertension and established cardiovascular risk factors was evaluated. The research explored whether the combination, when compared with another common dual-therapy regimen, was associated with patterns in the occurrence of a composite major cardiovascular event (such as heart attack, stroke, and cardiovascular death). The study populations involved high-risk adults with pre-existing conditions like Coronary Artery Disease (CAD) or Type 2 Diabetes Mellitus.

Understanding Research Gaps and Uncertainty

The evidence from studies that examined serious health events was derived primarily from a single, large trial with a mean follow-up duration of approximately three years. This duration was shorter than planned, meaning long-term effects are not fully established beyond that period for this specific comparative study. Evidence is limited regarding how the studied combination compares to all other available treatment options, and findings describe group patterns, not personal outcomes.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amlibon B Sandoz (FAQ)

Q: How is Amlibon B Sandoz different from other common blood pressure medications?

A: Amlibon B Sandoz is a fixed-dose combination product containing two distinct antihypertensive agents: a Calcium Channel Blocker (amlodipine) and an ACE Inhibitor (benazepril).

Official prescribing documents describe this medication as being used when a patient’s blood pressure is not adequately controlled by treatment with a single component alone.


Q: Is ankle swelling (edema) from Amlibon B Sandoz dangerous, or just a nuisance?

A: Swelling of the ankles or feet, known as edema, is listed in regulatory documents as a common side effect of this medicine. However, it is important to distinguish this from Angioedema, a rare but serious reaction involving severe swelling of the face, throat, or tongue.

Angioedema is a potentially life-threatening reaction and is a reaction described as requiring immediate medical evaluation.


Q: How quickly does Amlibon B Sandoz start working to lower blood pressure?

A: The amlodipine component achieves its highest blood concentration within 6 to 12 hours after taking a dose.

While the drug begins to act quickly, regulatory documents describe allowing approximately two weeks between dosage adjustments to fully assess the long-term therapeutic response of the combined medicine.


Q: What are the known long-term effects of taking Amlibon B Sandoz for many years?

A: Long-term studies have shown the combination is associated with effective and sustained blood pressure control over several years of use.

Regulatory documents note that clinical data used for approval often have a mean follow-up duration of a few years, meaning specific long-term effects beyond that period are not fully established in comparative studies.


Q: Why do doctors prescribe Amlibon B Sandoz for chest pain (angina) and not just high blood pressure?

A: The amlodipine component of the medicine is formally indicated for the symptomatic treatment of two forms of chest pain: Chronic Stable Angina and Vasospastic Angina (Prinzmetal's or Variant Angina).

This is because its mechanism involves relaxing blood vessels, which increases the blood flow and oxygen supply capacity to the heart muscle tissue.


Q: Can I stop taking Amlibon B Sandoz once my blood pressure is under control?

A: Official information describes this medication as a long-term approach for managing a chronic condition like high blood pressure.

Suddenly stopping the medicine may cause blood pressure to rebound or increase, which could raise the risk of serious cardiovascular events, such as a heart attack or stroke.


Q: How does Amlibon B Sandoz affect my heart rate?

A: Common side effects do not include a change in heart rate, but palpitations (a fluttering or racing heart sensation) are noted as a less common side effect.

Very high serum levels of magnesium in interaction cases have been linked to bradycardia (slow heart rate).


Q: Does Amlibon B Sandoz make you feel dizzy when you stand up (orthostatic hypotension)?

A: The medicine can cause generalized dizziness and lightheadedness, particularly when treatment is first started.

This sensation is a direct result of the medication lowering blood pressure (hypotension). Changes in position may increase the feeling of lightheadedness.


Q: Can Amlibon B Sandoz be taken with multivitamins or herbal supplements?

A: Official drug information indicates that the amlodipine component can interact with some herbal products, such as St. John's wort, which may affect the drug's effectiveness.

Multivitamins containing high levels of certain minerals may also require caution. Official guidance emphasizes the importance of informing a healthcare provider about all prescription, over-the-counter medicines, and supplements being used.


Q: Does Amlibon B Sandoz affect male sexual function or cause erectile dysfunction?

A: Erectile dysfunction (ED) has been reported as an uncommon side effect of the amlodipine component in post-marketing reports.

The medicine is also known to interact with certain ED medications, which can cause excessive drops in blood pressure when combined.


Q: What should I do if I notice yellowing of my skin or eyes while on Amlibon B Sandoz?

A: Official patient information indicates that yellowing of the skin or eyes (jaundice) is a sign of a rare, serious adverse reaction involving potential liver problems (Hepatic Failure).

Regulatory sources describe this as a symptom associated with serious risk that warrants prompt medical evaluation.


Q: Are there any long-term kidney effects from taking Amlibon B Sandoz?

A: The medicine is generally not recommended for use in patients with severe renal impairment (poor kidney function) due to the benazepril component.

The regulatory label indicates that regular monitoring of kidney function and electrolyte levels may be necessary, particularly when starting therapy.


Q: Does Amlibon B Sandoz cause weight gain, and if so, why?

A: Both weight gain and weight loss have been noted in post-marketing reports as possible, though not common, side effects.

The most frequent side effect, ankle and leg swelling (edema), involves fluid accumulation in the tissues, which may contribute to a perceived increase in body weight.


Q: Is it safe to take ibuprofen or other NSAIDs while using Amlibon B Sandoz?

A: Regulatory sources indicate that combining this medication with NSAIDs (Nonsteroidal Anti-inflammatory Drugs) such as ibuprofen may increase blood pressure or potentially reduce kidney function.

Official information states that patients should discuss the use of NSAIDs with a healthcare provider before combining them, especially if there are pre-existing kidney issues or high blood pressure.


Q: Can Amlibon B Sandoz affect my ability to drive or operate machinery?

A: Official patient information states that this medicine can cause some people to feel dizzy, lightheaded, or sleepy.

If these effects occur, official safety information indicates that activities requiring full mental alertness, such as driving, should be avoided.


Q: Does Amlibon B Sandoz interact with common supplements like magnesium or potassium?

A: The benazepril component can cause an increase in potassium levels in the blood (hyperkalemia).

Patients are cautioned against using potassium supplements or salt substitutes unless specifically directed by a healthcare provider. High doses of magnesium may also cause excessively low blood pressure.


Q: Can Amlibon B Sandoz cause tiredness or feeling sluggish?

A: Post-marketing reports and the safety profile include the terms 'asthenia' and 'fatigue', which are used to describe unusual tiredness or a lack of energy.

These effects are considered part of the overall adverse reaction profile of the medication.


Q: What is the connection between Amlibon B Sandoz and gum swelling (gingival hyperplasia)?

A: Gingival hyperplasia (gum swelling) has been reported as an adverse reaction associated with the amlodipine component of the drug.

This is a recognized, though not universal, side effect among some classes of calcium channel blockers.


Q: Is it common to have nausea or stomach discomfort after taking this medicine?

A: Nausea is listed in the official adverse reaction profile as a potential side effect of the medicine.

Abdominal pain has also been reported. In the rare context of liver problems, nausea is considered a key symptom that should be noted.


Q: Can Amlibon B Sandoz cause mood changes, anxiety, or depression?

A: The safety profile lists nervousness as a less common side effect.

This medication is also noted to interact with some medicines used for mood stabilization. The safety profile indicates that monitoring for unusual changes in mood or behavior may be necessary.


Q: How does taking Amlibon B Sandoz affect blood sugar levels for someone without diabetes?

A: Post-marketing reports have noted cases of hyperglycemia (high blood sugar) in patients using this medication.

Additionally, the medicine is known to interact with certain diabetes medications, which can affect blood sugar balance.


Q: Is there a risk of withdrawal symptoms if the medication is stopped suddenly?

A: Stopping the medicine without proper guidance carries the risk of a sharp increase in blood pressure.

This uncontrolled increase may significantly raise the chance of experiencing serious cardiovascular events, such as a heart attack or stroke.


Q: Can Amlibon B Sandoz be split or crushed if I have trouble swallowing the tablet?

A: Official patient information for the combination product indicates that the capsule can be opened and the contents mixed with a small amount of water or soft food for administration.

This allows patients who have difficulty swallowing the whole capsule to still take their full, prescribed dose.


Q: What does the term 'Vasospastic Angina' mean in relation to this drug?

A: Vasospastic Angina (also called Prinzmetal's or Variant Angina) is a type of chest pain caused by temporary, unexpected spasms of the arteries that supply blood to the heart.

The amlodipine component is specifically indicated to treat this condition by promoting the relaxation and widening of the coronary arteries.


Q: Is it safe to drink alcohol while I am taking Amlibon B Sandoz?

A: Alcohol may have additive effects in lowering blood pressure.

This combination of effects can increase the risk of side effects such as excessive dizziness, lightheadedness, and fainting.


Q: Is the swelling in the ankles caused by fluid retention or something else?

A: Regulatory literature describes the swelling (edema) caused by the amlodipine component as being due to a change in the pressure within the small blood vessels.

This increased pressure causes a small amount of fluid to move out of the vessels and into the surrounding tissue spaces.


Q: Do I need to monitor my blood pressure at home while taking Amlibon B Sandoz?

A: Regular tracking of blood pressure is essential for assessing how effectively the medication is controlling the chronic condition.

Official prescribing strategy supports home blood pressure monitoring as a tool to help track the medicine's effectiveness throughout the day and over time.


Q: Is there a link between Amlibon B Sandoz and muscle cramps or joint pain?

A: Joint pain (arthralgia) is noted in post-marketing reports as an uncommon side effect associated with the amlodipine component.

Additionally, symptoms such as muscle weakness or cramping have been reported, often related to possible electrolyte imbalances caused by the drug.


Q: Why is my blood pressure still high even though I take Amlibon B Sandoz every day?

A: Blood pressure management is part of a comprehensive, individualized treatment plan.

If the blood pressure is not adequately controlled, it may indicate that a higher dose, a different combination, or further medical investigation is necessary to address underlying factors.


Q: Does Amlibon B Sandoz help prevent heart attacks or strokes directly?

A: Official regulatory documents indicate that lowering high blood pressure with this drug reduces the risk of both fatal and nonfatal cardiovascular events.

This includes a reduction in the risk of strokes and myocardial infarctions (heart attacks).


Q: Can I take Amlibon B Sandoz if I have asthma or other breathing issues?

A: While the drug is not widely contraindicated in asthma, severe breathing trouble or wheezing can be a symptom of a serious allergic reaction, particularly Angioedema.

Angioedema is a serious adverse reaction noted in the regulatory warnings that is described as requiring immediate medical evaluation.


Q: What are the inactive ingredients in Amlibon B Sandoz that might cause a reaction?

A: The inactive ingredients in the capsule formulation may include common components like lactose anhydrous, magnesium stearate, titanium dioxide, and various iron oxides.

Individuals with known sensitivities are referred to the official patient information leaflet for the specific list of ingredients in the formulation being used.


Q: Does Amlibon B Sandoz affect cholesterol levels?

A: This medication is not indicated for treating high cholesterol itself.

However, it is known to interact with certain cholesterol-lowering medications, such as Simvastatin, which may lead to an increase in the cholesterol drug's levels and a higher risk of its side effects.

Advertisements

How should Amlibon B Sandoz be stored and disposed of?

How to Store and Dispose of Amlibon B Sandoz

The storage and disposal of Amlibon B Sandoz (Amlodipine/Benazepril) must follow official regulatory requirements to maintain product stability.


Storage Conditions

Requirement Official Specification
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C.
Protection Keep in the original container and protected from moisture.
Child Safety Must be kept out of the reach and sight of children.

Disposal

Unused or expired Amlibon B Sandoz must be disposed of according to local regulations. The official guidance specifies that this medication should not be flushed down a toilet or poured into a drain unless specifically instructed to do so, to avoid environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlibon B Sandoz found in:

A-Z Index: